Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
BMC Cancer|March 13, 2025
Identifying distinct prognostic and predictive contributions of tumor epithelium versus tumor microenvironment in colorectal cancerMingli Yang, Michael V Nebozhyn, Michael J Schell, et al.NPJ Breast Cancer|October 2, 2025
Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapyJavier Cortes, Oleg Lipatov, Seock-Ah Im, et al.Molecular Cancer Therapeutics|June 4, 2016
High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to VintafolideAmy D Guertin, Jennifer O'Neil, Alexander Stoeck, et al.Journal for Immunotherapy of Cancer|July 3, 2023
Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trialKohei Shitara, Maria Di Bartolomeo, Mario Mandala, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group studyEvanthia Galanis, Kurt A Jaeckle, Matthew J Maurer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumorsIan Krop, Tim Demuth, Tina Guthrie, et al.Cancer Immunology Research|February 21, 2020
Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell CarcinomaHandan Xiang, Carlo P Ramil, Josephine Hai, et al.The Journal of Experimental Medicine|February 10, 2021
Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing miceFilippo Veglia, Ayumi Hashimoto, Harsh Dweep, et al.Cancer Research|May 17, 2008
Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphomaValeria R Fantin, Andrey Loboda, Cloud P Paweletz, et al.Journal of Biomolecular Screening|July 28, 2016
Development of a High-Throughput Gene Expression Screen for Modulators of RAS-MAPK Signaling in a Mutant RAS Cellular ContextBryan Severyn, Thi Nguyen, Michael D Altman, et al.Pageof 7